P3 Health Partners (PIII) Price & Analysis

Compare

115 Followers

PIII Stock Chart & Stats

Day’s Range― - ―

52-Week Range$5.80 - $29.15

Previous CloseN/A

Volume132.39K

Average Volume (3M)11.19K

Market Cap

$57.43M

Enterprise Value$216.69M

Total Cash (Recent Filing)$40.08M

Total Debt (Recent Filing)$182.90M

Price to Earnings (P/E)―

Beta1.06

Next Earnings

Nov 18, 2025

EPS Estimate

-5.71

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-6.23

Shares Outstanding3,268,218

10 Day Avg. Volume8,347

30 Day Avg. Volume11,192

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap3.77

Enterprise Value/Revenue0.15

Enterprise Value/Gross Profit-7.81

Enterprise Value/Ebitda-1.14

Forecast

1Y Price Target

$8.00

Price Target Upside0.13% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Cost ManagementInitiatives the management team is implementing, especially with its stronger focus on exiting unprofitable markets and reworking risk-based contracts, lead to a more favorable profit outlook and lower cash burn.

Market PerformanceInvestors should focus on the stable cost trend development in 2025, especially since three out of four markets are performing at breakeven or positively.

Operational ImprovementsPIII highlighted that it is ahead of schedule with respect to the previously announced ~$130M of adjusted EBITDA improvements.

Bears Say

Cash PositionThe cash balance of ~$40.1M seems low to analysts when compared to the use of cash of ~($33.5M) in 1Q:25, and debt of ~$106M.

Earnings ImpactOne difficult payer had a material impact to earnings in 1Q:25, resulting in a significant decline in medical margin.

Financial GuidanceManagement lowered fiscal 2025 adjusted EBITDA guidance by $39 million at the midpoint.

P3 Health Partners News

P3 Health Partners assumed with a Buy at Lake Street

Lake Street assumed coverage of P3 Health Partners (PIII) with a Buy rating and $20 price target Despite...

11h ago

PIII

P3 Health Partners reports Q2 EPS ($6.23) vs ($7.37) last year

Reports Q2 revenue $355.788M, consensus $359.43M. “Our core business continues to strengthen as we execute on our $130...

14d ago

PIII

P3 Health Partners sees FY25 revenue $1.35B-$1.5B, consensus $1.43B

Sese FY25 adjusted EBITDA ($69M)-($39M) Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

14d ago

PIII

P3 Health Partners Inc trading resumes

09:50 EDT P3 Health Partners (PIII) Inc trading resumes Published first on TheFly – the ultimate source for...

29d ago

PIII

P3 Health Partners Inc trading halted, volatility trading pause

09:30 EDT P3 Health Partners (PIII) Inc trading halted, volatility trading pause Published first on TheFly – the...

29d ago

PIII

P3 Health Partners Reports Q2 2025 Financial Results

P3 Health Partners Inc. ( ($PIII) ) has released its Q2 earnings. Here is a breakdown of the...

14d ago

PIII

Is PIII a Buy, Before Earnings?

P3 Health Partners Inc. (PIII) is scheduled to report 2nd quarter earnings on 08/14/2025, after the market closes....

17d ago

PIII

P3 Health Partners Appoints New Board Director

P3 Health Partners ( ($PIII) ) just unveiled an update. On July 2, 2025, Dr. Sherif Abdou resigned...

2M ago

PIII

P3 Health Partners’ Shareholders Approve Key Proposals

P3 Health Partners ( ($PIII) ) has provided an update. On June 4, 2025, P3 Health Partners Inc....

3M ago

PIII

P3 Health Partners Secures $70M Financing Deal

An announcement from P3 Health Partners ( ($PIII) ) is now available. On May 29, 2025, P3 Health...

3M ago

PIII

P3 Health Partners price target lowered to $8 from $12.50 at TD Cowen

TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to $8 from $12.50 and keeps...

3M ago

PIII

P3 Health Partners’ Earnings Call: Strategic Gains Amid Challenges

P3 Health Partners Inc. (($PIII)) has held its Q1 earnings call. Read on for the main highlights of...

3M ago

PIII

P3 Health Partners: Positioned for Growth with Strategic Initiatives and Profitability Improvements

William Blair analyst Ryan Daniels has maintained their bullish stance on PIII stock, giving a Buy rating today....

3M ago

PIII

P3 Health Partners Reports Q1 2025 Financial Results

P3 Health Partners Inc. ( ($PIII) ) has released its Q1 earnings. Here is a breakdown of the...

3M ago

PIII

PIII FAQ

What was P3 Health Partners’s price range in the past 12 months?

P3 Health Partners lowest stock price was $5.80 and its highest was $29.15 in the past 12 months.

What is P3 Health Partners’s market cap?

P3 Health Partners’s market cap is $57.43M.

When is P3 Health Partners’s upcoming earnings report date?

P3 Health Partners’s upcoming earnings report date is Nov 18, 2025 which is in 82 days.

How were P3 Health Partners’s earnings last quarter?

P3 Health Partners released its earnings results on Aug 14, 2025. The company reported -$6.23 earnings per share for the quarter, missing the consensus estimate of -$5.855 by -$0.375.

Is P3 Health Partners overvalued?

According to Wall Street analysts P3 Health Partners’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does P3 Health Partners pay dividends?

P3 Health Partners does not currently pay dividends.

What is P3 Health Partners’s EPS estimate?

P3 Health Partners’s EPS estimate is -5.71.

How many shares outstanding does P3 Health Partners have?

P3 Health Partners has 3,268,218 shares outstanding.

What happened to P3 Health Partners’s price movement after its last earnings report?

P3 Health Partners reported an EPS of -$6.23 in its last earnings report, missing expectations of -$5.855. Following the earnings report the stock price went down -2.305%.

Which hedge fund is a major shareholder of P3 Health Partners?

Currently, no hedge funds are holding shares in PIII

P3 Health Partners Stock Smart Score

Underperform

Fundamentals

Return on Equity

-138.17%

Trailing 12-Months

Asset Growth

-18.05%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

P3 Health Partners

P3 Health Partners (PIII) is a healthcare services company that focuses on improving patient outcomes and lowering healthcare costs through a value-based care model. The company operates in the healthcare sector, specifically targeting primary care services. P3 Health Partners collaborates with primary care providers and healthcare facilities to enhance care delivery, emphasizing preventive care and chronic disease management.

P3 Health Partners (PIII) Earnings & Revenues

Historic Earnings Reports

PIII Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call reflects both the challenges and progress P3 Health Partners is experiencing. While there are significant improvements in operational performance and strategic initiatives, financial metrics like EBITDA and membership decline present ongoing challenges. The company is on a positive trajectory with long-term strategies potentially yielding further gains, yet near-term financial hurdles remain.View all PIII earnings summaries

PIII Stock 12 Month Forecast

Average Price Target

$8.00

▲(0.13% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","18":"$18","31":"$31","11.5":"$11.5","24.5":"$24.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,11.5,18,24.5,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.35,7.3999999999999995,7.449999999999999,7.5,7.55,7.6,7.6499999999999995,7.7,7.75,7.8,7.85,7.9,7.95,{"y":8,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.35,7.3999999999999995,7.449999999999999,7.5,7.55,7.6,7.6499999999999995,7.7,7.75,7.8,7.85,7.9,7.95,{"y":8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.35,7.3999999999999995,7.449999999999999,7.5,7.55,7.6,7.6499999999999995,7.7,7.75,7.8,7.85,7.9,7.95,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":28.9,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.5,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.24,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.94,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.24,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.02,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.87,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.34,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.35,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >